Andrew Js Coats,Giuseppe Rosano
Andrew Js Coats
Cardiac Rehabilitation in Patients With Heart Failure: New Perspectives in Exercise Training [0.03%]
心脏康复在心力衰竭患者中的应用：运动训练的新视角
Maurizio Volterrani,Ferdinando Iellamo
Maurizio Volterrani
Exercise training is recommended to patients with chronic heart failure (CHF) and reduced ejection fraction at a class 1 evidence level. Currently the 'dose' of exercise (dose being both volume and intensity) still remains uncertain and the...
Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days [0.03%]
心血管外科重症监护病房的休克管理：银色岁月
Till Hauffe,Bernard Krüger,Dominique Bettex et al.
Till Hauffe et al.
Shock in cardio-surgical intensive care unit (ICU) patients requires prompt identification of the underlying condition and timely therapeutic interventions. Management during the first 6 hours, also referred to as "the golden hours", is of ...
Mohammad S Alzahri,Anita Rohra,W Frank Peacock
Mohammad S Alzahri
The purpose of this article is to review the clinical efficacy and safety of nitrates in acute heart failure (AHF) by examining various trials on nitrates in AHF. Management of AHF can be challenging due to the lack of objective clinical ev...
Should Angiotensin Receptor Neprilysin Inhibitors Replace Angiotensin-converting Enzyme Inhibitors in Heart Failure With a Reduced Ejection Fraction? [0.03%]
血管紧张素受体脑啡肽酶抑制剂能替代心力衰竭射血分数降低患者的标准血管紧张素转换酶抑制剂治疗吗？
Sam Hayman,John J Atherton
Sam Hayman
Angiotensin-converting enzyme inhibitors (ACEIs) have been the cornerstone of treatment of heart failure with reduced ejection fraction (HFrEF) for over two decades. Inhibition of neprilyisin augments vasoactive substances including natriur...
Juan Tamargo Menendez
Juan Tamargo Menendez
Heart failure (HF) represents a growing financial burden on healthcare systems and despite therapeutic advances, mortality remains high. Current treatments focus on blocking neurohormonal pathways, such as the renin-angiotensin aldosterone ...
Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure? [0.03%]
心衰合并房颤时β受体阻滞剂与地高辛的序贯及联合应用临床研究
Laurent Fauchier,Guillaume Laborie,Nicolas Clementy et al.
Laurent Fauchier et al.
In patients with atrial fibrillation (AF) and heart failure (HF) with or without systolic dysfunction, either rhythm control or rate control is an acceptable primary therapeutic option. If a rate control strategy is chosen, treatment with a...
John Anthony,Karen Sliwa
John Anthony
Heart disease is a common cause of morbidity and mortality during pregnancy. Symptoms and signs of heart failure in a pregnant woman are an indication for urgent assessment to establish a diagnosis and appropriate management. This is best a...
Gabriele Fragasso
Gabriele Fragasso
Activation of the neuro-hormonal system is a pathophysiological consequence of heart failure. Neuro-hormonal activation promotes metabolic changes, such as insulin resistance, and determines an increased use of non-carbohydrate substrates f...
Andrew Js Coats,Giuseppe Rosano
Andrew Js Coats